-
Je něco špatně v tomto záznamu ?
MLSB-Resistant Staphylococcus aureus in Central Greece: Rate of Resistance and Molecular Characterization
S. Sarrou, E. Malli, K. Tsilipounidaki, Z. Florou, M. Medvecky, A. Skoulakis, J. Hrabak, CC. Papagiannitsis, E. Petinaki,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
PubMed
30403546
DOI
10.1089/mdr.2018.0259
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky farmakologie MeSH
- bakteriální proteiny genetika MeSH
- fylogeneze MeSH
- genotyp MeSH
- lidé MeSH
- linkosamidy farmakologie MeSH
- makrolidy farmakologie MeSH
- methicilin rezistentní Staphylococcus aureus účinky léků genetika MeSH
- mikrobiální testy citlivosti metody MeSH
- mnohočetná bakteriální léková rezistence genetika MeSH
- stafylokokové infekce farmakoterapie mikrobiologie MeSH
- streptogramin B farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Řecko MeSH
The aim of the present study was to determine the rate and mechanisms of resistance to macrolides, lincosamides, and streptogramin B (MLSB) antibiotics of Staphylococcus aureus collected in Central Greece. Of the 2,893 S. aureus collected during 2012-2017, 1,161 isolates (40.2%) exhibited resistance to at least one of the MLSB agents. The rate of erythromycin resistance was statistically significantly higher in methicillin-resistant S. aureus (MRSA) (58.6%) than in methicillin-sensitive S. aureus (MSSA) isolates (20.7%) (p = 0.002). Two hundred seventy-five representative MLSB-resistant S. aureus, including 81 MSSA and 194 MRSA isolates, were further studied. Thirty-eight MSSA isolates carried ermC, 26 MSSA were positive for ermA, whereas 17 isolates carried msrA gene. Among MRSA, the ermA gene was identified in the majority of the isolates (n = 153). Thirty-seven MRSA isolates carried ermC; three isolates carried msrA, whereas the remaining MRSA was positive for two genes (ermA and ermC). Phylogenetic analysis showed that ST225, which belongs to CC5, was the most prevalent, accounting for 137 MRSA isolates. Higher genetic diversity was found in the group of MSSA isolates, which comprised of 13 sequence types. Whole-genome sequencing data showed that all ermA-positive S. aureus, with the exception of one ST398 isolate, harbored the ermA-carrying Tn554 transposon integrated into their chromosomes. Furthermore, Illumina sequencing followed by polymerase chain reaction screening identified that ermC, which was identified in a polyclonal population of MSSA and MRSA isolates, was carried by small plasmids, like pNE131. These findings highlighted the important role of high-risk clones and of mobile elements carrying resistance genes in the successful dissemination of MLSB-resistant staphylococci.
Department of Microbiology University Hospital of Larissa Larissa Greece
Faculty of Medicine Biomedical Center Charles University Pilsen Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045154
- 003
- CZ-PrNML
- 005
- 20200115131408.0
- 007
- ta
- 008
- 200109s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/mdr.2018.0259 $2 doi
- 035 __
- $a (PubMed)30403546
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Sarrou, Stela $u 1 Department of Microbiology, University Hospital of Larissa, Larissa, Greece.
- 245 10
- $a MLSB-Resistant Staphylococcus aureus in Central Greece: Rate of Resistance and Molecular Characterization / $c S. Sarrou, E. Malli, K. Tsilipounidaki, Z. Florou, M. Medvecky, A. Skoulakis, J. Hrabak, CC. Papagiannitsis, E. Petinaki,
- 520 9_
- $a The aim of the present study was to determine the rate and mechanisms of resistance to macrolides, lincosamides, and streptogramin B (MLSB) antibiotics of Staphylococcus aureus collected in Central Greece. Of the 2,893 S. aureus collected during 2012-2017, 1,161 isolates (40.2%) exhibited resistance to at least one of the MLSB agents. The rate of erythromycin resistance was statistically significantly higher in methicillin-resistant S. aureus (MRSA) (58.6%) than in methicillin-sensitive S. aureus (MSSA) isolates (20.7%) (p = 0.002). Two hundred seventy-five representative MLSB-resistant S. aureus, including 81 MSSA and 194 MRSA isolates, were further studied. Thirty-eight MSSA isolates carried ermC, 26 MSSA were positive for ermA, whereas 17 isolates carried msrA gene. Among MRSA, the ermA gene was identified in the majority of the isolates (n = 153). Thirty-seven MRSA isolates carried ermC; three isolates carried msrA, whereas the remaining MRSA was positive for two genes (ermA and ermC). Phylogenetic analysis showed that ST225, which belongs to CC5, was the most prevalent, accounting for 137 MRSA isolates. Higher genetic diversity was found in the group of MSSA isolates, which comprised of 13 sequence types. Whole-genome sequencing data showed that all ermA-positive S. aureus, with the exception of one ST398 isolate, harbored the ermA-carrying Tn554 transposon integrated into their chromosomes. Furthermore, Illumina sequencing followed by polymerase chain reaction screening identified that ermC, which was identified in a polyclonal population of MSSA and MRSA isolates, was carried by small plasmids, like pNE131. These findings highlighted the important role of high-risk clones and of mobile elements carrying resistance genes in the successful dissemination of MLSB-resistant staphylococci.
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a bakteriální proteiny $x genetika $7 D001426
- 650 _2
- $a mnohočetná bakteriální léková rezistence $x genetika $7 D024901
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a linkosamidy $x farmakologie $7 D055231
- 650 _2
- $a makrolidy $x farmakologie $7 D018942
- 650 _2
- $a methicilin rezistentní Staphylococcus aureus $x účinky léků $x genetika $7 D055624
- 650 _2
- $a mikrobiální testy citlivosti $x metody $7 D008826
- 650 _2
- $a fylogeneze $7 D010802
- 650 _2
- $a stafylokokové infekce $x farmakoterapie $x mikrobiologie $7 D013203
- 650 _2
- $a streptogramin B $x farmakologie $7 D025381
- 651 _2
- $a Řecko $7 D006115
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Malli, Ergina $u 1 Department of Microbiology, University Hospital of Larissa, Larissa, Greece.
- 700 1_
- $a Tsilipounidaki, Katerina $u 1 Department of Microbiology, University Hospital of Larissa, Larissa, Greece.
- 700 1_
- $a Florou, Zoi $u 1 Department of Microbiology, University Hospital of Larissa, Larissa, Greece.
- 700 1_
- $a Medvecky, Matej $u 2 Veterinary Research Institute, Brno, Czech Republic. 3 Faculty of Science, National Center for Biomolecular Research, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Skoulakis, Anargyros $u 1 Department of Microbiology, University Hospital of Larissa, Larissa, Greece.
- 700 1_
- $a Hrabak, Jaroslav $u 4 Faculty of Medicine, Biomedical Center, Charles University, Pilsen, Czech Republic.
- 700 1_
- $a Papagiannitsis, Costas C $u 1 Department of Microbiology, University Hospital of Larissa, Larissa, Greece.
- 700 1_
- $a Petinaki, Efi $u 1 Department of Microbiology, University Hospital of Larissa, Larissa, Greece.
- 773 0_
- $w MED00008749 $t Microbial drug resistance (Larchmont, N.Y.) $x 1931-8448 $g Roč. 25, č. 4 (2019), s. 543-550
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30403546 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200115131741 $b ABA008
- 999 __
- $a ok $b bmc $g 1483423 $s 1083827
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 25 $c 4 $d 543-550 $e 20181107 $i 1931-8448 $m Microbial drug resistance $n Microb Drug Resist $x MED00008749
- LZP __
- $a Pubmed-20200109